• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头颈部癌症同期放化疗期间吸入性肺炎患者的结局和预后因素。

The outcome and prognostic factors in patients with aspiration pneumonia during concurrent chemoradiotherapy for head and neck cancer.

机构信息

Department of Radiation Oncology, Taipei Medical University-Municipal Wan Fang Hospital, Taipei, Taiwan.

出版信息

Eur J Cancer Care (Engl). 2010 Sep;19(5):631-5. doi: 10.1111/j.1365-2354.2009.01104.x. Epub 2009 Aug 25.

DOI:10.1111/j.1365-2354.2009.01104.x
PMID:20109165
Abstract

This study aimed to investigate the outcome in patients with aspiration pneumonia during definitive concurrent chemoradiotherapy for head and neck cancer. The data of 595 patients with head and neck cancer treated by chemoradiotherapy were reviewed. Forty-one patients were identified as developing symptomatic aspiration pneumonia during treatment and were analysed for this study. The definition of symptomatic aspiration pneumonia fit three criteria: (1) at least one event of aspiration during the treatment or evidence of grade 2 or above dysphagia during treatment; (2) clinical or radiographic signs of pneumonia or pneumonitis; and (3) no evidence of grade 4 haematological toxicity before the outbreak of pneumonia. Termination of allocated radiotherapy was noted in 10 patients. A treatment break was observed in 26 patients, whereas irradiation was prolonged more than 1 week in 11 patients. Logistic regression analysis showed the dysphagia score during the treatment course and the chest roentgenography pattern following symptomatic aspiration pneumonia were found to independently influence the outcome. Aspiration pneumonia occurring during chemoradiotherapy for head and neck cancer has a detrimental effect on the treatment outcome. Intensive medical care is essential for this group of patients with a dysphagia score of 3 during treatment and an unfavourable chest film pattern.

摘要

本研究旨在探讨头颈部癌症根治性同期放化疗期间并发吸入性肺炎患者的结局。回顾了 595 例接受放化疗的头颈部癌症患者的数据。其中 41 例患者在治疗过程中出现有症状的吸入性肺炎,并对此进行了分析。有症状的吸入性肺炎的定义符合以下三个标准:(1) 在治疗过程中至少发生一次吸入事件,或在治疗过程中出现 2 级或以上吞咽困难的证据;(2) 出现肺炎或放射性肺炎的临床或影像学征象;(3) 在肺炎发作前无 4 级血液学毒性的证据。10 例患者停止了分配的放疗。26 例患者观察到治疗中断,11 例患者照射时间延长超过 1 周。Logistic 回归分析显示,治疗过程中的吞咽困难评分和有症状吸入性肺炎后胸部 X 线表现独立影响结局。头颈部癌症同期放化疗期间发生的吸入性肺炎对治疗结局有不利影响。对于这组在治疗过程中吞咽困难评分为 3 分且胸部 X 线片表现不佳的患者,需要进行强化医疗护理。

相似文献

1
The outcome and prognostic factors in patients with aspiration pneumonia during concurrent chemoradiotherapy for head and neck cancer.头颈部癌症同期放化疗期间吸入性肺炎患者的结局和预后因素。
Eur J Cancer Care (Engl). 2010 Sep;19(5):631-5. doi: 10.1111/j.1365-2354.2009.01104.x. Epub 2009 Aug 25.
2
Aspiration rate following chemoradiation for head and neck cancer: an underreported occurrence.头颈部癌放化疗后的误吸率:一种未被充分报道的情况。
Radiother Oncol. 2006 Sep;80(3):302-6. doi: 10.1016/j.radonc.2006.07.031. Epub 2006 Aug 4.
3
Factors associated with long-term dysphagia after definitive radiotherapy for locally advanced head-and-neck cancer.局部晚期头颈癌根治性放疗后长期吞咽困难的相关因素。
Int J Radiat Oncol Biol Phys. 2009 Feb 1;73(2):410-5. doi: 10.1016/j.ijrobp.2008.04.048. Epub 2008 Jul 16.
4
Risk factors for severe Dysphagia after concurrent chemoradiotherapy for head and neck cancers.头颈部癌同步放化疗后严重吞咽困难的危险因素。
Jpn J Clin Oncol. 2009 Jul;39(7):413-7. doi: 10.1093/jjco/hyp033. Epub 2009 Apr 20.
5
Long-term aspiration following treatment for head and neck cancer.头颈癌治疗后的长期误吸
Oncology. 2008;74(1-2):25-30. doi: 10.1159/000138976. Epub 2008 Jun 10.
6
Analysis of factors influencing Dysphagia severity following treatment of head and neck cancer.头颈癌治疗后吞咽困难严重程度的影响因素分析
Anticancer Res. 2009 Aug;29(8):3299-304.
7
Aspiration pneumonia in patients treated with radiotherapy for head and neck cancer.头颈部癌症放疗患者的吸入性肺炎。
Acta Oncol. 2013 Feb;52(2):270-6. doi: 10.3109/0284186X.2012.742205. Epub 2012 Nov 22.
8
Intensive chemoradiotherapy as a primary treatment for organ preservation in patients with advanced cancer of the head and neck: efficacy, toxic effects, and limitations.强化放化疗作为晚期头颈癌患者器官保留的主要治疗方法:疗效、毒性作用及局限性
Arch Otolaryngol Head Neck Surg. 2004 Jul;130(7):861-7. doi: 10.1001/archotol.130.7.861.
9
Safety and effectiveness of prophylactic gastrostomy tubes for head and neck cancer patients undergoing chemoradiation.预防性胃造瘘管在接受放化疗的头颈癌患者中的安全性和有效性。
Surg Oncol. 2006 Dec;15(4):199-203. doi: 10.1016/j.suronc.2006.12.002. Epub 2007 Feb 5.
10
Effects of treatment intensification on acute local toxicity during radiotherapy for head and neck cancer: prospective observational study validating CTCAE, version 3.0, scoring system.治疗强化对头颈部癌放疗期间急性局部毒性的影响:验证CTCAE 3.0版评分系统的前瞻性观察研究
Int J Radiat Oncol Biol Phys. 2008 Feb 1;70(2):330-7. doi: 10.1016/j.ijrobp.2007.06.022. Epub 2007 Sep 19.

引用本文的文献

1
Establishment and Validation of a Predictive Model for Radiation-Associated Aspiration Pneumonia in Patients with Radiation-Induced Dysphagia after Nasopharyngeal Carcinoma.建立并验证鼻咽癌放疗后吞咽障碍患者放射性相关吸入性肺炎的预测模型。
Behav Neurol. 2022 Aug 19;2022:6307804. doi: 10.1155/2022/6307804. eCollection 2022.
2
Aspiration pneumonia in head and neck cancer patients undergoing concurrent chemoradiation from India: Findings from a post hoc analysis of a phase 3 study.头颈部癌症患者同期放化疗后并发吸入性肺炎:来自一项 3 期研究的事后分析结果。
Cancer Med. 2021 Oct;10(19):6725-6735. doi: 10.1002/cam4.4210. Epub 2021 Sep 8.
3
Respiratory and pulmonary complications in head and neck cancer patients: Evidence-based review for the COVID-19 era.
头颈部癌症患者的呼吸和肺部并发症:COVID-19 时代的循证综述。
Head Neck. 2020 Jun;42(6):1218-1226. doi: 10.1002/hed.26217. Epub 2020 Apr 30.
4
Risk factors for aspiration pneumonia after definitive chemoradiotherapy or bio-radiotherapy for locally advanced head and neck cancer: a monocentric case control study.局部晚期头颈癌根治性放化疗或生物放疗后误吸性肺炎的危险因素:一项单中心病例对照研究。
BMC Cancer. 2017 Jan 17;17(1):59. doi: 10.1186/s12885-017-3052-8.
5
DARS: a phase III randomised multicentre study of dysphagia- optimised intensity- modulated radiotherapy (Do-IMRT) versus standard intensity- modulated radiotherapy (S-IMRT) in head and neck cancer.DARS:一项关于吞咽困难优化调强放疗(Do-IMRT)与标准调强放疗(S-IMRT)治疗头颈癌的III期随机多中心研究。
BMC Cancer. 2016 Oct 6;16(1):770. doi: 10.1186/s12885-016-2813-0.
6
Predictive factors of head and neck squamous cell carcinoma patient tolerance to high-dose cisplatin in concurrent chemoradiotherapy.头颈部鳞状细胞癌患者在同步放化疗中对高剂量顺铂耐受性的预测因素
Mol Clin Oncol. 2016 Feb;4(2):303-309. doi: 10.3892/mco.2015.687. Epub 2015 Nov 25.
7
Aspiration pneumonia after concurrent chemoradiotherapy for head and neck cancer.头颈部癌同步放化疗后吸入性肺炎
Cancer. 2015 Apr 15;121(8):1303-11. doi: 10.1002/cncr.29207. Epub 2014 Dec 23.
8
Incidence of pneumonia and risk factors among patients with head and neck cancer undergoing radiotherapy.头颈部癌症放疗患者肺炎的发生率及危险因素。
BMC Cancer. 2013 Aug 4;13:370. doi: 10.1186/1471-2407-13-370.
9
Aspiration pneumonia after chemo-intensity-modulated radiation therapy of oropharyngeal carcinoma and its clinical and dysphagia-related predictors.头颈部癌调强放疗后吸入性肺炎及其与临床和吞咽困难相关的预测因素。
Head Neck. 2014 Jan;36(1):120-5. doi: 10.1002/hed.23275. Epub 2013 Jun 1.
10
[Pneumonia Severity Index (PSI), CURB-65, and mortality in hospitalized elderly patients with aspiration pneumonia].[肺炎严重程度指数(PSI)、CURB-65与老年住院吸入性肺炎患者的死亡率]
Z Gerontol Geriatr. 2011 Aug;44(4):229-34. doi: 10.1007/s00391-011-0184-3.